Glenmark Pharmaceuticals Inc., USA

ADAPALENA

Dermatological pharmaceutical products;The wording ADAPALENA has no meaning in a foreign language.;

ADAPGLENA

Dermatological pharmaceutical products;The wording ADAPGLENA has no meaning in a foreign language.;

ADCYN

Dermatological pharmaceutical products; Pharmaceutical preparations for the prevention and treatment of the inflammation and itching caused by a number of skin conditions such as allergic reactions, eczema, and psoriasis; Corticosteroid preparations;

ADCYNO

Dermatological pharmaceutical products; Pharmaceutical preparations for the prevention and treatment of the inflammation and itching caused by a number of skin conditions such as allergic reactions, eczema, and psoriasis; Corticosteroid preparations;

ADSIN

Dermatological pharmaceutical products; Pharmaceutical preparations for the prevention and treatment of the inflammation and itching caused by a number of skin conditions such as allergic reactions, eczema, and psoriasis; Corticosteroid preparations;

ALYACEN

Oral contraceptives;

ASHLYNA

Oral contraceptives;

ATOFO

Dermatological pharmaceutical products;

BRIELLYN

Contraceptives; Hormones for medical purposes; Oral contraceptives;

CHARLOTTE

Oral contraceptives;

CHARLOTTE

Oral contraceptives;

CYNTALO

Dermatological pharmaceutical products; Pharmaceutical preparations for the prevention and treatment of the inflammation and itching caused by a number of skin conditions such as allergic reactions, eczema, and psoriasis; Corticosteroid preparations;

G GLENMARK

House mark for a full line of pharmaceutical preparations.;G GLEN MARK;Pharmaceutical Inc.;

GLENMARK

House mark for pharmaceutical and chemical preparations;GLEN MARK;

GLENMARK GENERICS INC., USA

Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for skin care; Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the metabolic system, the respiratory system, the musculo-skeletal system, the genitourinary system; for the treatment of inflammatory disorders; for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of joint disease; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Pharmaceutical preparations for the treatment of eye diseases and conditions; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for wounds; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical preparations, namely, anticoagulants; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Preparation for the relief of pain; Opium alkaloid preparations; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations;GLEN MARK GENERICS INC., USA;GENERICS INC., USA;

GLENMARK PHARMACEUTICALS INC., USA

House mark for a full line of pharmaceutical and chemical preparations;PHARMACEUTICAL INC., USA;

HAILEY

Oral contraceptives;

HEATHER

Contraceptives; Hormones for medical purposes; Oral contraceptives;

JORDYNA

Oral contraceptives;

KALOSAR

Dermatological preparations for the treatment of hyperproliferative diseases;

KALOSAR

Dermatological pharmaceutical products;

LYNITY

Oral contraceptives;

MARLISSA

Oral contraceptives;

NUEMUE

Dermatological pharmaceutical products;

PIRNUO

Dermatological pharmaceutical products;

PIRNUO

Dermatological pharmaceutical products;

QUMYLUS

Dermatological pharmaceutical products;

SIPROTI

Dermatological preparations for the treatment of hyperproliferative diseases;

STRAMUCIN

Dermatological pharmaceutical products;

SYMPREVIA

Oral contraceptives;

VIORELE

Contraceptives; Hormones for medical purposes; Oral contraceptives;